Ovarian cancer

A new study has revealed that Black women from Caribbean and African backgrounds are more likely to be diagnosed with certain types of cancer at later stages, when treatment is less likely to be successful. 

Research from the International Cancer Benchmarking Partnership has found a link between cancer policy consistency over time and survival for six cancer types

Three new treatment options made available for cancer patients in Scotland.

In 1999, Menon joined Professor Ian Jacobs to set up the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). 20 years later, the results are in.

A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer.

25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off.

Researchers have found an existing ovarian cancer blood test is far more predictive than originally thought and could potentially pick up other forms of cancer.

The latest ovarian cancer data from the ICBP reveals that while more people are surviving their cancer, there’s still a long way to go.

The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland

Our scientists are growing a living ovarian cancer biobank in Manchester.